Literature DB >> 3039170

Identification of proteins encoded by the L1 and L2 open reading frames of human papillomavirus 1a.

J Doorbar, P H Gallimore.   

Abstract

The human papillomavirus 1 (HPV-1) virion is composed of two virally encoded proteins: a 57,000-molecular-weight polypeptide (57K polypeptide), which is the product of the L1 open reading frame (ORF), and a 78K polypeptide, which is derived from the L2 ORF. The 57K (L1) product, which represents the major structural component, appears to be disulfide cross-linked in virus particles. The 78K (L2) protein is a minor component of the virion and does not appear to be disulfide linked either to the L1 gene product or to itself. Analysis of virus particles banding at different buoyant densities revealed differences in the L2 content of heavy-full and light-full virions. Antiserum prepared against a bacterially expressed fragment of the L1 ORF was found by immunofluorescence to cross-react with HPV-2 and bovine papillomavirus 1 virions in wart sections. No cross-reactivity was observed with antisera prepared against either the N- or C-terminal halves of the L2-encoded protein. Similarly, antisera prepared against purified virus particles (disrupted and nondisrupted) reacted only with an expressed fragment of the L1 ORF and not with either L2-encoded polypeptides or proteins derived from the E1, E2, E4, E6, or E7 ORFs. This indicates that the L1 protein contains the papillomavirus common antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3039170      PMCID: PMC255788          DOI: 10.1128/JVI.61.9.2793-2799.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Structural polypeptides of rabbit, bovine, and human papillomaviruses.

Authors:  M Favre
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

2.  Partial characterization of the proteins of human papilloma viruses (HPV) 1-3.

Authors:  H Pfister; L Gissmann; H zur Hausen
Journal:  Virology       Date:  1977-11       Impact factor: 3.616

3.  Papova virus group.

Authors:  J L MELNICK
Journal:  Science       Date:  1962-03-30       Impact factor: 47.728

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  Papovaviridae.

Authors:  J L Melnick; A C Allison; J S Butel; W Eckhart; B E Eddy; S Kit; A J Levine; J A Miles; J S Pagano; L Sachs; V Vonka
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Biology and biochemistry of papillomaviruses.

Authors:  H Pfister
Journal:  Rev Physiol Biochem Pharmacol       Date:  1984       Impact factor: 5.545

8.  Characterization of a new type of human papillomavirus that causes skin warts.

Authors:  G Orth; M Favre; O Croissant
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

9.  Human papillomavirus type 16 DNA sequence.

Authors:  K Seedorf; G Krämmer; M Dürst; S Suhai; W G Röwekamp
Journal:  Virology       Date:  1985-08       Impact factor: 3.616

10.  Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins.

Authors:  K K Stanley; J P Luzio
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  50 in total

1.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection.

Authors:  R B Roden; P M Day; B K Bronzo; W H Yutzy; Y Yang; D R Lowy; J T Schiller
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Characterization of a human papillomavirus type 16 variant-dependent neutralizing epitope.

Authors:  R B Roden; A Armstrong; P Haderer; N D Christensen; N L Hubbert; D R Lowy; J T Schiller; R Kirnbauer
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Identification of the alpha6 integrin as a candidate receptor for papillomaviruses.

Authors:  M Evander; I H Frazer; E Payne; Y M Qi; K Hengst; N A McMillan
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Human papillomavirus type 1 produces redundant as well as polycistronic mRNAs in plantar warts.

Authors:  D A Palermo-Dilts; T R Broker; L T Chow
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  Production and characterization of human proliferative T-cell clones specific for human papillomavirus type 1 E4 protein.

Authors:  J C Steele; T Stankovic; P H Gallimore
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18.

Authors:  Valerie Laniosz; Kha C Nguyen; Patricio I Meneses
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

9.  Characterization of murine polyclonal antisera and monoclonal antibodies generated against intact and denatured human papillomavirus type 1 virions.

Authors:  N Yaegashi; S A Jenison; J M Valentine; M Dunn; L B Taichman; D A Baker; D A Galloway
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

10.  Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines.

Authors:  M Sapp; C Fligge; I Petzak; J R Harris; R E Streeck
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.